Aquagenic Palmoplantar Keratoderma

Aquagenic palmoplantar keratoderma is a rare skin condition where the skin of the palms (and sometimes the soles) becomes very wrinkled, puffy, pale/white or translucent, pebbly, and sometimes burning or itchy after only a few minutes of contact with water (tap water, soapy water, pool water, sea water). The changes usually appear within 1–5 minutes of water exposure and fade within 10–30 minutes after drying. Many people feel tightness, tingling, stinging, or mild pain. It can happen at any age but is seen more in teens and young adults, and often in women. APK is strongly linked to cystic fibrosis (CF) and even to the CF carrier state (people who carry one CF gene), but it can also be drug-induced or idiopathic (no clear cause). The leading theory is that salt and water handling in the outer skin and sweat ducts is abnormal, so water is drawn quickly into the stratum corneum (the top skin layer) and around the eccrine sweat ducts, making the skin swell and wrinkle fast. DermNet®+2PMC+2

Aquagenic palmoplantar keratoderma (APPK) is a rare skin condition where the skin of the palms (and sometimes soles) quickly becomes swollen, white, wrinkled, and may sting, itch, or burn after very brief contact with water (often within 30–180 seconds). The changes fade after drying. Many people have no other health problems. However, APPK is much more common in people who have cystic fibrosis (CF) or carry one CF gene variant. Researchers think salt and water handling in the outer skin and the sweat ducts is different in these people, so the skin soaks up water more quickly and the tiny sweat duct openings swell. This makes the skin look puffy, pebbly, and over-wrinkled. Treatments often target sweat production, sweat duct activity, and the skin barrier; options include strong antiperspirants (aluminum chloride), anticholinergic medicines (e.g., glycopyrrolate—topical or oral), botulinum toxin injections when hyperhidrosis is prominent, and in severe, resistant cases, procedures for excessive sweating. There is no single “best” therapy; care is individualized. PMC+2DermNet®+2

---

Other Names

Doctors and journals have used several names for the same or very similar patterns:

• Aquagenic wrinkling of the palms (AWP) – the most common modern term, especially when the palms are mainly affected. DermNet®

• Aquagenic syringeal acrokeratoderma (ASA) – emphasizes changes around sweat ducts (syringes) in the palms/soles. PMC

• Aquagenic (pseudo)keratoderma / aquagenic keratoderma – another widely used label in reports and reviews. PMC+1

• Transient reactive aquagenic (pseudo)keratoderma – highlights the short-lasting, water-triggered reaction. Lippincott Journals

• “Hand-in-the-bucket sign” – not a diagnosis, but a classic clue: patients show the changes by dipping a hand in water. BioMed Central

Note: “Hereditary papulotranslucent acrokeratoderma” is a different, chronic condition with similar-looking papules but not strictly water-triggered.

---

Types

1. CF-related APK – occurs in people with cystic fibrosis. Often very fast wrinkling and prominent white plaques appear after brief water contact. CFTR (the CF gene) controls salt/water movement; when it is impaired, the stratum corneum soaks water rapidly. JAMA Network+1

2. CF carrier–associated APK – similar changes can occur in carriers (one faulty CFTR gene). Time-to-wrinkling tends to be shorter when CFTR function is lower. PubMed

3. Drug-induced APK – reported with COX-2 inhibitors (celecoxib, rofecoxib), aspirin, isotretinoin, and, in CF, tobramycin. Stopping the trigger drug can improve the condition. PubMed+4PubMed+4eScholarship+4

4. Hyperhidrosis-linked APK – many patients have palmar hyperhidrosis (excess sweating). Abnormal sweat salt concentration or sweat duct structure may amplify water uptake and wrinkling. Lippincott Journals+1

5. Idiopathic APK – no clear cause is found. The clinical pattern is the same, and it still responds to topical antiperspirants, anticholinergics, or botulinum toxin in some cases. PMC

6. Hereditary/familial variants – rare families show aquagenic wrinkling with palmoplantar hyperhidrosis; mutations in AQP5 (aquaporin-5) have been described as a possible mechanism of altered water movement in sweat gland-rich skin. BioMed Central

7. Sole-predominant or palm-plus-sole APK – the classic site is the palms, but similar, rarer changes may occur on the soles, especially in heavy water exposure. PMC

---

Causes

1. Cystic fibrosis (CF) – the strongest known association. CFTR dysfunction alters sweat salt balance and makes the outer skin absorb water rapidly, causing early, excessive wrinkling. APK can be a clue to unrecognized CF. JAMA Network+1

2. CF carrier state – even with only one CFTR mutation, some carriers show fast aquagenic wrinkling; this is important for genetic counseling. PubMed

3. Celecoxib (COX-2 inhibitor) – multiple case reports link celecoxib to APK; proposed mechanism: increased sodium content in epidermis raises water uptake. PubMed

4. Rofecoxib (COX-2 inhibitor) – earlier case reports mirror celecoxib-induced changes; resolving after drug withdrawal supports causality. PubMed

5. Aspirin (acetylsalicylic acid) – unilateral cases have been documented; stopping aspirin improved the wrinkling. PubMed

6. Isotretinoin – recent reports describe APK triggered by isotretinoin; barrier and autonomic effects may increase water penetration. PubMed+1

7. Tobramycin in CF – an aminoglycoside sometimes used in CF; a case linked treatment to onset of APK. PubMed

8. Palmar hyperhidrosis – excess sweating areas often match the wrinkling pattern, suggesting sweat duct involvement and higher surface salt. Lippincott Journals

9. Frequent hand washing / prolonged water exposure – more water exposure (e.g., during outbreaks with increased hygiene) can reveal or worsen APK. Lippincott Journals

10. Atopic tendency (asthma/allergic rhinitis/atopic skin) – some series note atopic histories; drier, more permeable skin may soak water faster. Lippincott Journals

11. High salt/sweat electrolyte concentration – a shared pathway: saltier sweat draws water into the stratum corneum by osmosis and swells the skin. PMC

12. Eccrine sweat duct structural changes – microscopy shows prominent eccrine ostia and ductal changes in some patients, facilitating water entry. Open Access LMU

13. Altered aquaporin channels (e.g., AQP5) – rare hereditary cases suggest water channels in sweat-rich skin can increase water influx. BioMed Central

14. Tight occlusion or gloves – occlusion traps sweat and water against the skin, speeding wrinkling in predisposed people (clinical observation within reviews). PMC

15. Warm water exposure – warmth increases sweat and blood flow, possibly intensifying the reaction. (Discussed in case reviews.) PMC

16. Soap/surfactant exposure – soaps can strip lipids and thin the barrier, so water gets in faster; several case reports note worse wrinkling after soapy water. PMC

17. Genetic variants beyond CFTR (suspected) – some idiopathic cases may have undetected channel or barrier gene variants; ongoing reviews mention this research direction. PubMed

18. Autonomic/small-fiber dysregulation – fingertip water-immersion wrinkling is tied to sympathetic vasoconstriction; altered autonomic tone may lower the threshold. Lippincott Journals

19. Concurrent skin inflammation (eczema, irritant dermatitis) – inflamed skin has higher permeability, so wrinkling can be accentuated. (Synthesis from clinical reviews.) PMC

20. Unknown / multifactorial – many patients have no single cause; water, sweat salt, barrier state, and medications likely interact. PMC

---

Symptoms

1. Very fast wrinkling after water – usually within 1–5 minutes (faster than normal wrinkling). DermNet®

2. Pale/white, translucent papules that look pebbly or spongy. PMC

3. Tightness or stiffness in the skin while wet. DermNet®

4. Burning or stinging sensation during water contact. DermNet®

5. Itching with water exposure for some people. DermNet®

6. Mild pain or tenderness of the wrinkled areas. PMC

7. Prominent sweat pores (enlarged eccrine openings) becoming visible as dots. Open Access LMU

8. Yellowish or whitish plaques coalescing from many small papules. Mayo Clinic Proceedings

9. Hyperlinearity and exaggerated skin markings when wet. JAMA Network

10. Quick resolution when dry – usually fades in 10–30 minutes. jaadcasereports.org

11. Worse with warm water or soapy water, better with cool water in some. PMC

12. Focal pattern – tends to match zones of hyperhidrosis on starch-iodine testing. Lippincott Journals

13. Soles sometimes involved (less common). PMC

14. Asymmetry when drug-induced or when exposure differs (e.g., one hand). PubMed

15. No scarring and normal-looking skin between episodes. DermNet®

---

Diagnostic Tests

A) Physical Examination (at the clinic)

1. “Hand-in-the-bucket” (water-immersion) test – hands immersed in room-temperature water; wrinkling and papules appear within minutes in APK, confirming the trigger. DermNet®

2. Time-to-wrinkling measurement – clinicians note how many minutes to first papules; very short times suggest APK and may correlate with CFTR dysfunction. PubMed

3. Pattern mapping – doctor looks for focal areas and compares with sweating zones; APK often matches hyperhidrosis areas. Lippincott Journals

4. Symptom provocation with warm vs cool water – warmth can accelerate changes; simple in-office comparison helps characterization. PMC

5. Observation of eccrine pores – enlarged dots and pits may be seen at the surface during episodes. Open Access LMU

B) Manual / Bedside Tests

6. Minor’s iodine–starch test – maps hyperhidrosis; areas that stain dark (heavy sweat) often overlap APK lesions. Lippincott Journals

7. Dermoscopy (handheld skin scope) – shows “gruyère-like” pores, wood-bark-like ridging, and enlarged eccrine ostia during water-exposed episodes. JAAD+2Lippincott Journals+2

8. Wood’s lamp as adjunct – recent reports describe enhancement of the pattern under Wood’s light after immersion, aiding recognition. PMC

9. Photographic documentation – before/after immersion photos help track severity and response to treatment (standard clinical practice in reports). PMC

10. Warm vs. room-temperature comparison test – repeating immersion at different temperatures can show threshold differences (helps patient counseling). PMC

C) Laboratory & Pathology

11. Sweat chloride test – the standard screening test for cystic fibrosis; APK should prompt CF/CF-carrier screening when appropriate. JAMA Network

12. CFTR genetic testing – confirms CF or carrier state; important when APK is the first clue. PubMed

13. Skin biopsy (histology) – may show compact hyperkeratosis, spongiosis, and dilated/accentuated eccrine ducts; helps exclude other keratodermas. PMC

14. Special stains / immunostains – may highlight eccrine duct changes; occasionally used in difficult cases as reported in case series/reviews. PMC

15. Sweat electrolyte analysis (research/selected cases) – explores salt content that can drive osmosis; more used in studies than routine care. PMC

D) Electrodiagnostic / Sweat Function Testing

16. Water-immersion wrinkling as autonomic test – fingertip wrinkling reflects sympathetic vasoconstriction; exaggerated/rapid wrinkling supports APK physiology. Lippincott Journals

17. QSART (quantitative sudomotor axon reflex test) – evaluates sweat gland nerve reflexes; not required for diagnosis but can profile sweat function when needed (used in sudomotor literature and referenced in APK reviews). PMC

18. Sympathetic skin response (SSR) – measures autonomic-related skin conductance; rarely used specifically for APK but conceptually aligns with the wrinkling reflex. Lippincott Journals

E) Imaging (non-invasive skin imaging)

19. Reflectance confocal microscopy (RCM) – in vivo microscopy can show changes in the upper epidermis and eccrine ostia during water exposure. PubMed+1

20. High-definition optical coherence tomography (HD-OCT) – cross-sectional skin imaging visualizes stratum corneum swelling and micro-architectural changes after immersion. PubMed+1

Non-pharmacological treatments (therapies & practical measures)

Below are practical, low-risk steps people commonly try. Evidence quality ranges from expert opinion and case reports to small series; there are no large trials yet. I list the purpose and likely mechanism in simple terms.

1. Dry-work strategies – Use tools (tongs, gloves) to avoid wet work when possible. Purpose: reduce water contact. Mechanism: fewer water triggers → fewer flares. DermNet®

2. Barrier ointment before water – A thin layer of petrolatum or silicone barrier cream 10–15 min before water tasks. Purpose: block water entry. Mechanism: occlusive film reduces swelling. (Expert practice notes.) DermNet®

3. Cool-water & time-limited exposure – Prefer brief, cool rinses over long, warm soaks. Purpose: lower trigger intensity. Mechanism: less vasodilation and water absorption. DermNet®

4. Air-dry or pat-dry immediately – Keep a towel nearby; dry hands right away. Purpose: shorten wet time. Mechanism: quicker evaporation → less swelling persistence. DermNet®

5. Antiperspirant technique optimization – Apply 20% aluminum chloride at night to dry skin; wash off in the morning. Purpose: reduce palmar sweating that aggravates AWP. Mechanism: plugs sweat ducts and reduces sweat output. DermNet®

6. Iontophoresis (home device for sweaty hands) – Regular sessions with tap-water iontophoresis. Purpose: reduce hyperhidrosis that worsens AWP. Mechanism: decreases sweat production through electrical current effect on sweat glands. PMC

7. Powder-in-glove trick – Light dusting of absorbent powder under nitrile gloves for wet tasks. Purpose: reduce maceration. Mechanism: absorbs moisture; limits friction. (Practical expert tip.) DermNet®

8. Choose nitrile over latex – Nitrile gloves are less occlusive and less allergenic for many users. Purpose: comfort during wet work. Mechanism: reduces sweating/irritation under gloves. (Practical expert tip; general dermatology practice.) DermNet®

9. Gentle cleansers – Use fragrance-free, pH-balanced hand wash. Purpose: protect barrier. Mechanism: less irritation → stronger stratum corneum. (General dermatitis care principles.) DermNet®

10. Regular emollients after water – Thick, fragrance-free creams with urea or glycerin. Purpose: repair barrier; reduce sting. Mechanism: humectants and lipids restore hydration balance. (General skin care guidance.) DermNet®

11. Task clustering – Do wet chores in one block rather than many times per day. Purpose: fewer triggers. Mechanism: cuts the number of water exposures. (Behavioral strategy.) DermNet®

12. Cool compresses during flares – Brief cool packs after water. Purpose: soothe burning/itch. Mechanism: vasoconstriction and reduced nerve firing. (Symptomatic care.) DermNet®

13. Mind-body pain skills – Box breathing, brief relaxation when burning peaks. Purpose: pain modulation. Mechanism: lowers sympathetic overactivity that may drive sweat. (Adjunctive.) PMC

14. CF carrier/CF evaluation when indicated – If AWP is prominent or early in life, ask your clinician about CFTR testing or CF assessment. Purpose: find an associated cause. Mechanism: AWP is common in CF and carriers. PMC+1

15. Medication review – Ask about NSAIDs/COX-2 inhibitors if AWP began after starting them. Purpose: remove a trigger. Mechanism: rare drug-induced cases reported with celecoxib/rofecoxib. PubMed

16. Salt-aware skincare – Rinse off sea water/chlorinated water quickly; moisturize after. Purpose: avoid extra salt that can worsen swelling. Mechanism: salt changes water movement in skin. (Physiology discussed in AWP literature.) PMC

17. Photograph flares – Keep pictures to show your clinician context and timing. Purpose: accurate diagnosis. Mechanism: documents transient changes. (Diagnostic tip.) DermNet®

18. Trigger diary – Note temperature, type of water, soaps, gloves, and symptoms. Purpose: personalize avoidance. Mechanism: identifies strongest triggers for you. (Self-management.) DermNet®

19. Education on benign course – Most cases are uncomfortable but not dangerous. Purpose: reduce anxiety. Mechanism: reassurance based on typical natural history. DermNet®

20. Specialist referral for procedures – If daily life is limited, see a dermatologist with hyperhidrosis expertise. Purpose: access advanced options (e.g., botulinum toxin). Mechanism: targeted sweat modulation. PMC

---

Drug treatments

IMPORTANT: Many of these are “off-label” for AWP/APPK. They should be prescribed and monitored by a clinician, especially in children or if you have other medical conditions.

1. Aluminum chloride 20% (topical antiperspirant) – Class: astringent/antiperspirant. How used: thin layer nightly to dry palms; wash off AM; reduce frequency once controlled. Purpose/mechanism: forms temporary plugs in sweat ducts; reduces sweating and water uptake. Common effects: irritation, stinging (use every other night or add moisturizer if needed). This is considered a first-line option. DermNet®

2. Aluminum chlorohydrate 15% gel (topical) – Class: antiperspirant. Timing: similar to above when 20% is too irritating. Purpose/mechanism: reduces sweat/duct activity. Side effects: local irritation. DermNet®

3. Topical glycopyrronium (e.g., 2–2.4% cloth/solution; compounded gel) – Class: anticholinergic. Use: once daily to palms; avoid touching eyes. Purpose/mechanism: blocks muscarinic receptors on sweat glands → less sweat and less water-induced swelling. Side effects: dry mouth, blurry vision if transferred to eyes; local irritation. Evidence includes case reports with improvement. PMC+1

4. Oral glycopyrrolate – Class: anticholinergic. Dose (typical adult ranges used for hyperhidrosis): 1–2 mg once or twice daily, titrated (doctor-directed). Purpose/mechanism: systemic sweat reduction. Side effects: dry mouth/eyes, constipation, urinary retention; avoid in glaucoma or certain GI/GU conditions. Case reports support benefit in AWP via sweat reduction. PMC

5. Oral oxybutynin – Class: anticholinergic (used for overactive bladder). Dose (hyperhidrosis practice): often 2.5–5 mg once/twice daily, titrated. Purpose/mechanism: lowers sweat output through muscarinic blockade. Side effects: similar anticholinergic profile; dose-dependent. Evidence is extrapolated from hyperhidrosis; occasional AWP reports. PMC

6. Botulinum toxin type A injections (palms) – Class: neurotoxin; Use: multiple small intradermal injections per palm every ~4–6 months. Purpose/mechanism: blocks acetylcholine release at sympathetic cholinergic fibers to sweat glands; robust sweat reduction and AWP improvement. Side effects: injection pain, temporary hand weakness, cost. Documented case success in AWP/APPK. PMC

7. Tap-water iontophoresis (with or without anticholinergic additive) – Class: device-assisted therapy. Schedule: several sessions per week, then maintenance. Purpose/mechanism: decreases sweat production; sometimes combined with glycopyrrolate solution. Side effects: dryness, mild irritation. Reported among effective options. PMC

8. Topical keratolytics (urea 20–40%; salicylic acid 3–6%) – Class: keratolytics. Use: once-twice daily to thickened areas. Purpose/mechanism: soften outer skin and improve texture after flares. Side effects: sting/irritation; avoid on fissures. Supportive measure in reviews. PMC

9. Topical corticosteroids (low-to-mid potency, brief) – Class: anti-inflammatory. Use: short courses for burning/itch if inflamed. Purpose/mechanism: calms secondary irritation; not a primary AWP fix. Side effects: skin thinning with prolonged use; use sparingly. Listed as possible adjunct by expert sources. DermNet®

10. Oral antihistamines (non-sedating by day; sedating at night) – Class: H1 blockers. Use: symptom control for itch/burning. Purpose/mechanism: reduces histamine-mediated symptoms; does not stop wrinkling itself. Side effects: drowsiness (first-gen). Included among reported symptomatic aids. PMC

11. Barrier creams with dimethicone – Class: occlusive/protective. Use: before water tasks. Purpose/mechanism: physical water barrier; reduces symptom intensity. Side effects: minimal. Expert practice. DermNet®

12. Glycopyrronium cloth “pulse” before exposures – Class: anticholinergic. Use: apply 30–60 min pre-wet work on high-trigger days. Purpose/mechanism: time treatment to exposure; minimize daily dosing. Side effects: as above. Case-based strategy. PMC

13. Aluminum chloride “pulsed” regimens – Class: antiperspirant. Use: nightly for 1–2 weeks, then maintenance 1–3 nights/week. Purpose/mechanism: sustain duct blockage; limit irritation. Side effects: local sting. First-line practice. DermNet®

14. Methenamine topical (hexamethylenetetramine, compounded) – Class: antiperspirant/antimicrobial by-product in acidic sweat. Use: occasional off-label trials for sweaty hands. Mechanism: reduces sweat/odor; evidence in AWP limited. Side effects: irritation. (Occasional hyperhidrosis practice; limited AWP data.) PMC

15. Capsaicin cream (very limited anecdotal use) – Class: TRPV1 agonist. Purpose: desensitize burning sensations. Caution: can initially burn/sting; no strong AWP data. Consider only with clinician guidance. PMC

16. Topical calcineurin inhibitors (tacrolimus/pimecrolimus) – Class: anti-inflammatory immunomodulators. Use: if steroid-sparing is needed for irritation. Mechanism: reduces inflammation; not core for AWP. Evidence: anecdotal. PMC

17. Topical aluminum lactate formulations – Class: antiperspirant/astringent. Mechanism: reduces sweating; data in AWP sparse but sometimes used in hyperhidrosis. Side effects: irritation. PMC

18. CFTR-modulator therapy (in people with CF only) – Class: CFTR potentiators/combination therapy (e.g., ivacaftor, etc.). Observation: AWP improved over time in CF patients on ivacaftor (case-series data). Mechanism: normalizes CFTR function in sweat/skin. Side effects: per CF protocols. Only for those with CF under specialist care. ScienceDirect

19. Lidocaine/prilocaine topical pre-procedure – Class: topical anesthetic. Purpose: reduce pain from botulinum injections. Mechanism: local nerve blockade. Side effects: local numbness; methemoglobinemia risk if misused. Adjunct only. PMC

20. Analgesics for post-procedure discomfort – Class: simple analgesics (e.g., acetaminophen). Purpose: comfort after injections/iontophoresis. Note: Avoid starting COX-2 inhibitors specifically for AWP; rare reports link celecoxib/rofecoxib to inducing AWP-like changes. PubMed

---

Dietary molecular supplements

Honest evidence check: There are no supplements proven to treat or cure AWP/APPK. Most advice focuses on reducing water triggers, sweat, and protecting the skin barrier. Below are supportive, low-risk ideas your clinician might consider alongside proven measures; they are adjuncts, not treatments for AWP itself.

1. Adequate hydration – prevents rebound sweating from dehydration/overheating; general skin comfort. (General principle; not AWP-specific.) DermNet®

2. Balanced dietary salt – avoid extremes; very salty environments/water may worsen swelling in some people; keep diet moderate. (Pathophysiology notes about salt and AWP.) PMC

3. Omega-3 fatty acids (food-first) – may support overall skin barrier/inflammation balance; no AWP trials. Discuss if you take anticoagulants. (General dermatology nutrition principle.) DermNet®

4. Vitamin D within normal range – good for immune/skin health in general; test-and-replace approach, not mega-doses. No AWP data. DermNet®

5. Biotin from food sources – widely marketed for skin/nails; no AWP-specific evidence; deficiency is rare on normal diets. DermNet®

6. Oral ceramides/collagen peptides – small cosmetic studies suggest improved hydration/TEWL in normal skin; none for AWP. If used, treat as cosmetic adjuncts. DermNet®

7. Probiotics (general gut-skin axis interest) – no AWP evidence; if you use them, choose reputable products and monitor tolerance. DermNet®

8. Green tea polyphenols (dietary) – theoretical anti-oxidant/anti-inflammatory benefit; no AWP data. DermNet®

9. Evening primrose oil (GLA) – mixed evidence for eczema symptoms; none for AWP; consider only with clinician advice. DermNet®

10. Avoid unregulated “sweat-stoppers” online – risk of adulterants/interactions; no proof for AWP. Stick to clinician-guided care. DermNet®

---

Immunity booster / regenerative / stem-cell drugs

There are no validated immune-booster, regenerative, or stem-cell drugs for AWP/APPK. Because AWP is mainly a sweat/skin-barrier phenomenon (often tied to CFTR), immunostimulants or stem-cell therapies are not indicated. Below I list 6 safer clarifications rather than unproven drugs:

1. Avoid immune boosters for AWP – no benefit; may interact with medicines. Focus on sweat control/barrier care. DermNet®

2. No stem-cell therapy for AWP – not studied; not recommended. DermNet®

3. Botulinum toxin ≠ regenerative drug – it’s a sweat-gland modulator with good symptomatic benefit in selected cases. PMC

4. CFTR modulators only for CF – disease-specific drugs that can improve AWP in people with CF, under CF specialist care. ScienceDirect

5. Healthy lifestyle “boosts” immunity generally – sleep, nutrition, exercise; useful for wellbeing but not a treatment for AWP. DermNet®

6. Discuss supplements or novel therapies with your clinician – to avoid interactions and false promises. DermNet®

---

Procedures/surgeries

1. Botulinum toxin A (in-office procedure) – Not surgery, but procedural; best evidence among interventions; strong option when hyperhidrosis drives AWP. PMC

2. Tap-water iontophoresis program – Device-based series with maintenance; helpful for sweaty palms and secondary AWP. PMC

3. Endoscopic thoracic sympathectomy (ETS) – Keyhole surgery that cuts or clips sympathetic nerves to permanently reduce hand sweating; last-line due to potential side effects (e.g., compensatory sweating). A case report notes surgery can give durable results for hyperhidrosis-linked AWP. ScienceDirect

4. Sweat-gland suction-curettage (limited role on palms) – Used mostly for axillae; palmar results are less predictable and risk nerve/vessel injury; rarely chosen. (Hyperhidrosis procedural literature—expert caution.) ScienceDirect

5. Microwave thermolysis/laser for sweat glands (palms) – Emerging/less established on palms compared with axillae; consider only in research/experienced centers. (Extrapolated hyperhidrosis tech; evidence sparse for AWP.) ScienceDirect

---

Prevention tips

1. Short, cool water contact; avoid long hot soaks. DermNet®

2. Nightly antiperspirant regimen (then taper). DermNet®

3. Barrier ointment before high-risk wet work. DermNet®

4. Nitrile gloves + brief breaks to air hands. DermNet®

5. Gentle cleansers; no fragrances/harsh soaps. DermNet®

6. Moisturize after each wash (urea/glycerin creams). DermNet®

7. Keep hands cool; manage stress to reduce sweating. PMC

8. Review new meds if AWP appeared after starting them (especially COX-2 inhibitors). PubMed

9. Photograph flares to track patterns and progress with your clinician. DermNet®

10. Seek specialist care if daily life is limited—more options exist. PMC

---

When to see a doctor

• If palmar pain/burning is frequent, intense, or disrupting work/school.

• If you notice very rapid, dramatic wrinkling within seconds of water (especially in a child/teen) or you have personal/family history of cystic fibrosis—ask about CFTR testing. PMC+1

• If the skin cracks, bleeds, or looks infected.

• If over-the-counter antiperspirants/barriers fail after a careful 2–4-week trial.

• If AWP seems linked to a new medicine (e.g., celecoxib)—don’t stop on your own: discuss safe alternatives. PubMed

---

What to eat vs what to avoid

Eat more of:

• Regular fluids (avoid getting overheated, which triggers sweat).

• Balanced meals with fruits/vegetables, healthy fats (e.g., omega-3-rich fish), and adequate protein—good for general skin health.

Limit/avoid:

• Very salty broths/drinks right before long water work (some people report worse swelling then).

• Energy drinks and excess caffeine when you’ll be doing wet chores—these can increase sweating in some.

• Fad “immunity booster” pills sold online with unproven claims for AWP.

(Diet has a small role compared with direct skin measures; personalize by keeping a simple trigger diary.) DermNet®

---

FAQs

1) Is APPK dangerous?
No. It is uncomfortable and annoying but not dangerous by itself. The main risk is pain/functional impact and skin irritation. DermNet®

2) Why do my hands wrinkle so fast in water?
Your outer skin and sweat-duct openings let in water quickly, so the skin swells and looks pebbly within seconds. PMC

3) Do I need testing for cystic fibrosis?
Not always. But because AWP is common in CF and carriers, your clinician may consider CFTR testing if you’re young or have suggestive symptoms/history. PMC+1

4) What’s the best first treatment?
Nightly 20% aluminum chloride antiperspirant is often first-line; add moisturizers to reduce irritation. DermNet®

5) My hands burn—are there pain options?
Cool compresses, short courses of topical steroids for irritation, and oral antihistamines for itch can help; see a dermatologist for tailored care. PMC+1

6) Does botulinum toxin work?
Yes, in selected cases with hyperhidrosis; it reduces sweating and improves AWP for months at a time. PMC

7) Will iontophoresis help?
Often, yes—especially if you have sweaty palms. It’s a non-invasive device therapy with maintenance sessions. PMC

8) Are there pills I can take?
Anticholinergic pills (e.g., glycopyrrolate, oxybutynin) reduce sweating but can have dry-mouth, constipation, and other side effects; doctor supervision is needed. PMC

9) Can a new medicine cause AWP?
Rarely, yes. Cases link COX-2 inhibitors (like celecoxib) with AWP-like changes; never stop a prescription without medical advice. PubMed

10) Is this just “normal wrinkling”?
No. Normal wrinkling takes many minutes; AWP happens very fast, is more intense, and can burn or sting. DermNet®

11) Is it contagious?
No. It’s not an infection. DermNet®

12) Will it go away?
Some people improve with antiperspirants or procedures; others manage it long-term by reducing water triggers. Courses vary. DermNet®

13) Do moisturizers help?
Yes. They don’t stop the wrinkling itself but improve comfort and repair the barrier after water exposure. DermNet®

14) Should kids be treated differently?
Yes—gentler products, careful dosing, and clinician oversight. Consider CFTR discussion in pediatric cases. PMC

15) What’s one high-impact tip?
Use a strong antiperspirant at night + barrier ointment before wet tasks. Many people see a big difference with this combo. DermNet®

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 21, 2025.

PDF Documents For This Disease Condition References